company

BIOTRANS AS

0366 OSLO

Return on Equity
767,4 %
Current Ratio
2,96
Debt-to-Equity Ratio
22,15
Key figures (NOK)2022
Revenue25 426 000
Net Income2 778 000
Total Assets11 978 000
Total Equity362 000
Income (NOK)2022
Revenue25 426 000
Expenditure21 869 000
Operating Profit3 557 000
Financial Income6 000
Financial Costs5 000
Financial Balance1 000
Earnings Before Tax3 558 000
Tax780 000
Net Income2 778 000
Balance (NOK)2022
Total Fixed Assets1 328 000
Total Current Assets10 650 000
Total Assets11 978 000
Total Retained Equity332 000
Total Equity362 000
Total Long-Term Debt8 017 000
Total Current Debt3 600 000
Total Equity and Debt11 978 000
Cash flow (NOK)2022
Sales Income24 703 000
Other Income723 000
Revenue25 426 000
Cost of Goods Sold4 973 000
Salary Costs9 439 000
Depreciation584 000
Impairment0
Expenditure21 869 000
Operating Profit3 557 000
Financial Income6 000
Financial Costs5 000
Financial Balance1 000
Dividends0
Net Income2 778 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets24 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures968 000
Total Tangible Assets968 000
Total Fiancial Fixed Assets336 000
Total Fixed Assets1 328 000
Stock0
Total Investments0
Cash, Bank6 416 000
Total Current Assets10 650 000
Total Assets11 978 000
Total Equity362 000
Short-Term Group Debt0
Total Long-Term Debt8 017 000
Creditors654 000
Unpaid Taxes1 220 000
Dividends0
Other Current Debt980 000
Total Current Debt3 600 000
Total Equity and Debt11 978 000
Financial indicators2022
Return on Equity767,4 %
Debt-to-Equity Ratio22,15
Operating Profit Margin13,99 %
Current Ratio2,96
Quick Ratio2,96
Equity Ratio0,03
Gross Profit Margin80,44 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English